Literature DB >> 10530446

Escherichia coli: epidemiology and analysis of risk factors for infections caused by resistant strains.

D Lepelletier1, N Caroff, A Reynaud, H Richet.   

Abstract

This study analyzes the epidemiology of hospital and community-acquired infections caused by Escherichia coli. The antimicrobial resistance pattern was used to characterize the isolates, and a prospective observational study was performed to assess the relationship between antimicrobial use and bacterial resistance. The study was conducted during a 3-month period in a 1,200-bed tertiary care hospital in Nantes, France. An E. coli infection was diagnosed in 3.8% of the patients (507 of 13,384) admitted to the hospital between 1 January and 31 March 1996. Of the 507 isolates, 205 (40.4%) were resistant to at least one antimicrobial; 40% were resistant to amoxicillin, 30% to amoxicillin/clavulanate, 38% to ticarcillin, and 16% to trimethoprim-sulfamethoxazole, while resistance to other antimicrobials was low. Prior receipt of antimicrobial and/or immunosuppressive therapy was significantly associated with infection caused by a resistant organism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10530446     DOI: 10.1086/598632

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  8 in total

1.  Emergence of piperacillin/tazobactam-resistant Escherichia coli.

Authors:  I Mohammedi; S Tigaud; J P Tournadre
Journal:  Intensive Care Med       Date:  2000-10       Impact factor: 17.440

2.  Epidemiological survey of amoxicillin-clavulanate resistance and corresponding molecular mechanisms in Escherichia coli isolates in France: new genetic features of bla(TEM) genes.

Authors:  V Leflon-Guibout; V Speldooren; B Heym; M Nicolas-Chanoine
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

3.  Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study.

Authors:  A Sotto; C M De Boever ; P Fabbro-Peray; A Gouby; D Sirot; J Jourdan
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

Review 4.  Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance.

Authors:  Vered Schechner; Elizabeth Temkin; Stephan Harbarth; Yehuda Carmeli; Mitchell J Schwaber
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

5.  Risk factors for piperacillin/tazobactam-resistant Escherichia coli in ICU patients: a clinical study.

Authors:  Ismaël Mohammedi; Dominique Ploin; Serge Duperret; François Chapuis; Paul Petit
Journal:  Intensive Care Med       Date:  2003-05-27       Impact factor: 17.440

6.  Efficacy of Fluoroquinolone/Probiotic Combination Therapy for Recurrent Urinary Tract Infection in Children: A Retrospective Analysis.

Authors:  Ramiro J Madden-Fuentes; Mehreen Arshad; Sherry S Ross; Patrick C Seed
Journal:  Clin Ther       Date:  2015-07-29       Impact factor: 3.393

7.  The magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reported.

Authors:  Maureen K Bolon; Sharon B Wright; Howard S Gold; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

8.  Evaluation of Virulence Factors and Antibiotic Sensitivity Pattern of Escherichia Coli Isolated from Extraintestinal Infections.

Authors:  Ritu Vaish; Mss Pradeep; C R Setty; Venkataramana Kandi
Journal:  Cureus       Date:  2016-05-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.